Literature DB >> 14564656

Botulism type B presenting as pure autonomic dysfunction.

B Merz1, H Bigalke, G Stoll, M Naumann.   

Abstract

Botulism nowadays is a rare mostly food-borne disease caused by the toxin of Clostridium botulinum. On the other hand, botulinum toxin blocking cholinergic transmission has become a most powerful treatment option for many focal movement disorders and is increasingly used to treat autonomic disorders [2, 7, 8]. Although muscle weakness is the hallmark of botulism, autonomic dysfunction may be the leading clinical symptom in rare cases and should be included in the differential diagnosis of pure dysautonomia. Here, we describe a patient with autonomic dysfunction as the leading symptom of botulism type B.

Entities:  

Mesh:

Year:  2003        PMID: 14564656     DOI: 10.1007/s10286-003-0118-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  10 in total

Review 1.  Autonomic dysfunction in the neurological intensive care unit.

Authors:  Max J Hilz; Mao Liu; Sankanika Roy; Ruihao Wang
Journal:  Clin Auton Res       Date:  2018-07-18       Impact factor: 4.435

2.  Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.

Authors:  Agam K Rao; Jeremy Sobel; Kevin Chatham-Stephens; Carolina Luquez
Journal:  MMWR Recomm Rep       Date:  2021-05-07

Review 3.  Infectious diseases causing autonomic dysfunction.

Authors:  Francisco Javier Carod-Artal
Journal:  Clin Auton Res       Date:  2017-07-20       Impact factor: 5.625

Review 4.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

5.  Quantitative autonomic testing in the management of botulism.

Authors:  Raffi Topakian; Christoph Heibl; Karl Stieglbauer; Bettina Dreer; Markus Nagl; Peter Knoflach; Franz Thaddäus Aichner
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

6.  Long lasting dysautonomia due to botulinum toxin B poisoning: clinical-laboratory follow up and difficulties in initial diagnosis.

Authors:  Anna Potulska-Chromik; Beata Zakrzewska-Pniewska; Elżbieta Szmidt-Sałkowska; Jacek Lewandowski; Maciej Siński; Witold Przyjałkowski; Anna Kostera-Pruszczyk
Journal:  BMC Res Notes       Date:  2013-10-30

7.  Foodborne botulism due to ingestion of home-canned green beans: two case reports.

Authors:  Dorothea Hellmich; Katja E Wartenberg; Stephan Zierz; Tobias J Mueller
Journal:  J Med Case Rep       Date:  2018-01-04

8.  Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

Authors:  Christelle Mazuet; Christine Legeay; Jean Sautereau; Laurence Ma; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  Genome Biol Evol       Date:  2016-06-13       Impact factor: 3.416

9.  Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).

Authors:  Hans Bigalke; Andreas Rummel
Journal:  Toxins (Basel)       Date:  2015-11-25       Impact factor: 4.546

Review 10.  Toxemia in Human Naturally Acquired Botulism.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.